News Detail

Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54

PUBT · 06/22 20:10

Listen to the news

Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54

Tarsus Pharmaceuticals CEO, President, board chair Bobak R. Azamian sold 10,000 common shares on June 17.
Sales were priced at USD 61.24 to USD 61.81 per share.
Holdings in the reported trust fell to 847,991 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001827672-26-000009), on June 22, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.